1
|
Honushefsky A, Wagner ES, Sheridan K, Spickard KM, LeMasters WR, Walter CN, Beaver T, Lennon AM, Papadopoulos N, Rahm AK, Buchanan AH. Real-time evaluation and adaptation to facilitate rapid recruitment in a large, prospective cohort study. BMC Health Serv Res 2024; 24:336. [PMID: 38481315 PMCID: PMC10938733 DOI: 10.1186/s12913-024-10750-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Accepted: 02/19/2024] [Indexed: 03/17/2024] Open
Abstract
BACKGROUND Recruiting large cohorts efficiently can speed the translation of findings into care across a range of scientific disciplines and medical specialties. Recruitment can be hampered by factors such as financial barriers, logistical concerns, and lack of resources for patients and clinicians. These and other challenges can lead to underrepresentation in groups such as rural residents and racial and ethnic minorities. Here we discuss the implementation of various recruitment strategies for enrolling participants into a large, prospective cohort study, assessing the need for adaptations and making them in real-time, while maintaining high adherence to the protocol and high participant satisfaction. METHODS While conducting a large, prospective trial of a multi-cancer early detection blood test at Geisinger, an integrated health system in central Pennsylvania, we monitored recruitment progress, adherence to the protocol, and participants' satisfaction. Tracking mechanisms such as paper records, electronic health records, research databases, dashboards, and electronic files were utilized to measure each outcome. We then reviewed study procedures and timelines to list the implementation strategies that were used to address barriers to recruitment, protocol adherence and participant satisfaction. RESULTS Adaptations to methods that contributed to achieving the enrollment goal included offering multiple recruitment options, adopting group consenting, improving visit convenience, increasing the use of electronic capture and the tracking of data and source documents, staffing optimization via leveraging resources external to the study team when appropriate, and integrating the disclosure of study results into routine clinical care without adding unfunded work for clinicians. We maintained high protocol adherence and positive participant experience as exhibited by a very low rate of protocol deviations and participant complaints. CONCLUSION Recruiting rapidly for large studies - and thereby facilitating clinical translation - requires a nimble, creative approach that marshals available resources and changes course according to data. Planning a rigorous assessment of a study's implementation outcomes prior to study recruitment can further ground study adaptations and facilitate translation into practice. This can be accomplished by proactively and continuously assessing and revising implementation strategies.
Collapse
Affiliation(s)
| | - Eric S Wagner
- Geisinger, 549 Fair Street, Bloomsburg, PA, 17815, USA
| | | | | | | | | | - Taryn Beaver
- Geisinger, 549 Fair Street, Bloomsburg, PA, 17815, USA
| | | | | | | | | |
Collapse
|
2
|
Ryf C, Hofstetter L, Clack L, Hincapié CA. Involving patients and clinicians in the development of a randomised clinical trial protocol to assess spinal manual therapy versus nerve root injection for patients with lumbar radiculopathy: a patient and public involvement project to inform the SALuBRITY trial design. RESEARCH INVOLVEMENT AND ENGAGEMENT 2024; 10:8. [PMID: 38229190 DOI: 10.1186/s40900-023-00536-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2023] [Accepted: 12/22/2023] [Indexed: 01/18/2024]
Abstract
BACKGROUND Spinal manual therapy and corticosteroid nerve root injection are commonly used to treat patients with lumbar radiculopathy. The SALuBRITY trial-a two parallel group, double sham controlled, randomised clinical trial-is being developed to compare their effectiveness. By gathering patients' and clinicians' perspectives and involving them in discussions related to the trial research question and objectives, proposed trial recruitment processes, methods, and outcome measures, we aimed to improve the relevance and quality of the SALuBRITY trial. METHODS We involved patients with lived experience of lumbar radiculopathy (n = 5) and primary care clinicians (n = 4) with experience in the treatment of these patients. Involvement activities included an initial kick-off event to introduce the project, establishing a shared purpose statement, and empowering patient and clinician advisors for their involvement, followed by semi-structured group and individual interviews, and questionnaires to evaluate the experience throughout the project. RESULTS Both patient and clinician advisors endorsed the significance and relevance of the trial's objectives. Patients assessed the proposed trial methods as acceptable within the context of a trusting patient-clinician relationship. A trial recruitment and enrolment target time of up to five days was regarded as acceptable, although patients with chronic radiculopathy may need more time to consider their trial participation decision. All advisors reached consensus on the acceptability of a medication washout phase of 12- to 24-h before pain outcome measurement, with the inclusion of a rescue medication protocol. Both advisory groups preferred leg pain over back pain as the primary clinical outcome, with patient advisors advocating for personalized primary pain localization. Furthermore, patients requested expanding the pain, enjoyment, and general activity scale with peak pain intensity, rather than average pain alone. Patient and clinician advisors evaluated their engagement in clinical research as meaningful and impactful. CONCLUSION Patient and public involvement resulted in important and relevant considerations for the SALuBRITY trial, spanning all research phases. These findings hold promise for enhancing the trial's quality and relevance and improving its translation into clinical practice.
Collapse
Affiliation(s)
- Corina Ryf
- Department of Chiropractic Medicine, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
- EBPI-UWZH Musculoskeletal Epidemiology Research Group, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
| | - Léonie Hofstetter
- EBPI-UWZH Musculoskeletal Epidemiology Research Group, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
- Head of Musculoskeletal Epidemiology Research, Epidemiology, Biostatistics and Prevention Institute (EBPI) & University Spine Centre Zurich, Balgrist University Hospital, University of Zurich, Zurich, Switzerland
- University Spine Centre Zurich (UWZH), Balgrist University Hospital, University of Zurich, Zurich, Switzerland
| | - Lauren Clack
- Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
| | - Cesar A Hincapié
- EBPI-UWZH Musculoskeletal Epidemiology Research Group, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
- Head of Musculoskeletal Epidemiology Research, Epidemiology, Biostatistics and Prevention Institute (EBPI) & University Spine Centre Zurich, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
- University Spine Centre Zurich (UWZH), Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
| |
Collapse
|
3
|
Lee L, Hillier LM, Patel T, Lu SK, Lee M, Lee C. An innovative approach to recruiting participants for dementia research: primary care and researcher perspectives. Neurodegener Dis Manag 2023; 13:323-334. [PMID: 38284385 DOI: 10.2217/nmt-2022-0040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2024] Open
Abstract
Aim: To describe clinician and researcher perceptions of a new, patient preference focused approach to recruiting patients for research from primary care-based memory clinics. Methods: Memory clinic clinicians completed a survey and key informants completed an individual interview to gather their perceptions of this new program. Results: The majority of clinicians were 'satisfied' or 'very satisfied' with this recruitment approach and indicated that this approach would have minimal negative impact on patient care or create conflict of interest. Key informants valued the program for its patient-centred approach, the integration of research into care and potential for increased recruitment. Discussion: These findings are suggestive of support for this recruitment approach. Pilot testing will inform feasibility, effectiveness and process improvements.
Collapse
Affiliation(s)
- Linda Lee
- Centre for Family Medicine Family Health Team, 10 B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
- Department of Family Medicine, McMaster University, 100 Main Street West, Hamilton, Ontario, L8P 1H6, Canada
- Schlegel-University of Waterloo Research Institute for Aging, 250 Laurelwood Drive, Waterloo, Ontario, N2J 0E2, Canada
| | - Loretta M Hillier
- GERAS Centre for Aging Research, 88 Maplewood Ave, Hamilton, Ontario, L8M 1W9, Canada
| | - Tejal Patel
- Centre for Family Medicine Family Health Team, 10 B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
- School of Pharmacy, University of Waterloo, 10A Victoria Street South, Waterloo, Ontario, N2G 1C5, Canada
| | - Stephanie K Lu
- Centre for Family Medicine Family Health Team, 10 B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
| | - Michael Lee
- Centre for Family Medicine Family Health Team, 10 B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
| | - Catherine Lee
- Centre for Family Medicine Family Health Team, 10 B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
| |
Collapse
|
4
|
Myers R, Hallman MH, Davis K, DiCarlo M, Daskalakis C, Shimada A, Chambers C. Primary care provider perspectives on a planned multi-cancer early detection test clinical trial. Contemp Clin Trials Commun 2023; 34:101183. [PMID: 37456505 PMCID: PMC10345238 DOI: 10.1016/j.conctc.2023.101183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 06/19/2023] [Accepted: 07/02/2023] [Indexed: 07/18/2023] Open
Affiliation(s)
- Ronald Myers
- Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut Street, The Franklin Building, Suite 314, Philadelphia, PA, 19107, USA
| | - Mie H. Hallman
- Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut Street, The Franklin Building, Suite 314, Philadelphia, PA, 19107, USA
| | - Kaitlyn Davis
- Department of Family and Community Medicine, Thomas Jefferson University, 1015 Walnut St., Suite 401, Philadelphia, PA, 19107, USA
| | - Melissa DiCarlo
- Department of Medical Oncology, Thomas Jefferson University, 834 Chestnut Street, The Franklin Building, Suite 314, Philadelphia, PA, 19107, USA
| | - Constantine Daskalakis
- Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 1015 Chestnut Street, Suite 520, Philadelphia, PA, 19107, USA
| | - Ayako Shimada
- Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, 1015 Chestnut Street, Suite 520, Philadelphia, PA, 19107, USA
| | - Christopher Chambers
- Department of Family and Community Medicine, Thomas Jefferson University, 1015 Walnut St., Suite 401, Philadelphia, PA, 19107, USA
| |
Collapse
|
5
|
Budaraju D, Neelapu BC, Pal K, Jayaraman S. Stacked machine learning models to classify atrial disorders based on clinical ECG features: a method to predict early atrial fibrillation. BIOMED ENG-BIOMED TE 2023:bmt-2022-0430. [PMID: 36963433 DOI: 10.1515/bmt-2022-0430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2022] [Accepted: 02/20/2023] [Indexed: 03/26/2023]
Abstract
OBJECTIVES Atrial Tachycardia (AT) and Left Atrial Enlargement (LAE) are atrial diseases that are significant precursors to Atrial Fibrillation (AF). There are ML models for ECG classification; clinical features-based classification is required. The suggested work aims to create stacked ML models that categorize Sinus Rhythm (SR), Sinus Tachycardia (ST), AT, and LAE signals based on clinical parameters for AF prognosis. METHODS The classification was based on thirteen clinical parameters, such as amplitude, time domain ECG aspects, and P-Wave Indices (PWI), such as the ratio of P-wave length and amplitude ((P (ms)/P (µV)), P-wave area (µV*ms), and P-wave terminal force (PTFV1(µV*ms). Apart from classifying the ECG signals, the stacked ML models prioritized the clinical features using a pie formula-based technique. RESULTS The Stack 1 model achieves 99% accuracy, sensitivity, precision, and F1 score, while the Stack 2 model achieves 91%, 91%, 94%, and 92% for identifying SR, ST, LAE, and AT, respectively. Both stack models obtained a computational time of 0.06 seconds. PTFV1 (µV*ms), P (ms)/P (µV)), and P-wave area (µV*ms) were ranked as crucial clinical features. CONCLUSION Clinical feature-based stacking ML models may help doctors obtain insight into important clinical ECG aspects for early AF prediction.
Collapse
Affiliation(s)
- Dhananjay Budaraju
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| | - Bala Chakravarthy Neelapu
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| | - Kunal Pal
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| | - Sivaraman Jayaraman
- Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India
| |
Collapse
|
6
|
Venda Nova C, Ni Riordain R, Baker SR, Zakrzewska JM. An international Delphi survey and consensus meeting to define the core outcome set for trigeminal neuralgia clinical trials. Eur J Pain 2023; 27:86-98. [PMID: 36130737 PMCID: PMC10092666 DOI: 10.1002/ejp.2041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Revised: 09/08/2022] [Accepted: 09/17/2022] [Indexed: 12/15/2022]
Abstract
BACKGROUND Trigeminal neuralgia (TN) is an excruciating unilateral facial pain, which negatively affects patient's quality of life. Historically, it has been difficult to compare treatment efficacy due to the lack of standardized outcomes. In addition, patients' perspective has seldomly been acknowledged. The aim of this study was to reach consensus on what outcomes of treatment are important to different TN stakeholders (patients, clinicians and researchers), to identify the TN Core Outcome Set (TRINCOS). METHODS A list of outcomes identified through a systematic review and focus group work was used to develop the survey questionnaire. A three-round Delphi was conducted. Participants were asked to score the outcomes on scale from 1 to 9 (1-3 not important;4-6 important but not critical;7-9 critical). Outcomes scored as critical by ≥70% and not important by <15% were retained, and those for which no consensus was reached were discussed at a consensus meeting. RESULTS Of the 70 participants who completed the Delphi, 26 were patients, 38 were clinicians and six were researchers. Of the 40 outcomes presented, 17 were scored as critical and no consensus was met for 23 outcomes. Agreement was reached during a consensus meeting on 10 outcomes across six domains (pain, side effects, social impact, quality of life, global improvement, and satisfaction with treatment). CONCLUSION Implementation of TRINCOS in future clinical trials will improve homogeneity of studies' results, reduce the redundancy in the outcome assessment and effectively allow comparison of different treatments to better inform researchers, clinicians and most importantly patients, about the efficacy of the different treatments. SIGNIFICANCE Implementation of a 10-item core outcome set in trigeminal neuralgia will improve comparability between studies allowing patients to have faster access to better treatments.
Collapse
Affiliation(s)
| | - Richeal Ni Riordain
- University College London, Eastman Dental Institute, London, UK.,Cork University Dental School and Hospital, Cork, Ireland
| | - Sarah R Baker
- School of Clinical Dentistry, Sheffield University, Sheffield, UK
| | | |
Collapse
|
7
|
Millar MM, Taft T, Weir CR. Clinical trial recruitment in primary care: exploratory factor analysis of a questionnaire to measure barriers and facilitators to primary care providers' involvement. BMC PRIMARY CARE 2022; 23:311. [PMID: 36463123 PMCID: PMC9719201 DOI: 10.1186/s12875-022-01898-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Accepted: 11/03/2022] [Indexed: 12/05/2022]
Abstract
BACKGROUND Recruitment of sufficient participants for clinical trials remains challenging. Primary care is an important avenue for patient recruitment but is underutilized. We developed and pilot tested a questionnaire to measure relevant barriers and facilitators to primary care providers' involvement in recruiting patients for clinical trials. METHODS Prior research informed the development of the questionnaire. The initial instrument was revised using feedback obtained from cognitive interviews. We invited all primary care providers practicing within the University of Utah Health system to complete the revised questionnaire. We used a mixed-mode design to collect paper responses via in-person recruitment and email contacts to collect responses online. Descriptive statistics, exploratory factor analysis, Cronbach's alpha, and multivariable regression analyses were conducted. RESULTS Sixty-seven primary care providers participated in the survey. Exploratory factor analysis suggested retaining five factors, representing the importance of clinical trial recruitment in providers' professional identity, clinic-level interventions to facilitate referral, patient-related barriers, concerns about patient health management, and knowledge gaps. The five factors exhibited good or high internal consistency reliability. Professional identity and clinic-level intervention factors were significant predictors of providers' intention to participate in clinical trial recruitment activities. CONCLUSIONS Results of this exploratory analysis provide preliminary evidence of the internal structure, internal consistency reliability, and predictive validity of the questionnaire to measure factors relevant to primary care providers' involvement in clinical trial recruitment.
Collapse
Affiliation(s)
- Morgan M. Millar
- grid.223827.e0000 0001 2193 0096Department of Internal Medicine, University of Utah, 295 Chipeta Way, Salt Lake City, UT USA
| | - Teresa Taft
- grid.223827.e0000 0001 2193 0096Department of Biomedical Informatics, University of Utah, Salt Lake City, UT USA
| | - Charlene R. Weir
- grid.223827.e0000 0001 2193 0096Department of Biomedical Informatics, University of Utah, Salt Lake City, UT USA
| |
Collapse
|
8
|
Al Zaabi A, Busaidi N, Al Mutairy S, Yorgancıoğlu A, Aksu K, Al-Jahdali H, Wali S, Elsayed M, Beekman MJ. Overprescription of short-acting β 2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study. Expert Rev Respir Med 2022; 16:833-847. [PMID: 35848074 DOI: 10.1080/17476348.2022.2099841] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND Although short-acting β2-agonist (SABA) overuse is associated with poor treatment outcomes, data on SABA use in the Middle East are lacking. RESEARCH DESIGN AND METHODS In this cross-sectional study in patients (aged ≥12 years) with asthma, data on disease characteristics and asthma treatments were collected from the Middle Eastern cohort of the SABA use IN Asthma (SABINA) III study. Patients were classified by investigator-defined asthma severity and practice type. Multivariable regression models analyzed the association between SABA prescriptions and clinical outcomes. RESULTS Of 1389 patients (mean age, 46.7 years; female, 69.5%), 85.7% had moderate-to-severe asthma and 88.7% were treated by specialists. Overall, 51.3% of patients experienced ≥1 severe asthma exacerbation in the previous 12 months, with 58.2% having partly controlled or uncontrolled asthma. Notably, 47.1% of patients were prescribed ≥3 SABA canisters (considered overprescription). SABA canisters were purchased over the counter by 15.3% of patients. Higher SABA prescriptions (vs 1-2 canisters), except 3-5 canisters, were associated with increased odds of uncontrolled asthma (p<0.05). CONCLUSIONS SABA overprescription occurred in almost half of all patients in the Middle East, underscoring the need for healthcare providers and policymakers to adhere to the latest evidence-based recommendations to address this public health concern.
Collapse
Affiliation(s)
| | | | | | | | - Kurtuluş Aksu
- Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey
| | | | - Siraj Wali
- King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia
| | | | | |
Collapse
|
9
|
Yorgancıoğlu A, Aksu K, Naycı SA, Ediger D, Mungan D, Gül U, Beekman MJHI. Short-acting β 2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III. BMC Pulm Med 2022; 22:216. [PMID: 35655251 PMCID: PMC9161536 DOI: 10.1186/s12890-022-02008-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 04/28/2022] [Indexed: 11/10/2022] Open
Abstract
Background Over-reliance on short-acting β2-agonists (SABAs) is associated with poor asthma outcomes. However, the extent of SABA use in Turkey is unclear owing to a lack of comprehensive healthcare databases. Here, we describe the demographics, disease characteristics and treatment patterns from the Turkish cohort of the SABA use IN Asthma (SABINA) III study. Methods This observational, cross-sectional study included patients aged ≥ 12 years with asthma from 24 centres across Turkey. Data on sociodemographics, disease characteristics and asthma treatments were collected using electronic case report forms. Patients were classified by investigator-defined asthma severity (guided by the 2017 Global Initiative for Asthma [GINA]) and practice type (primary/specialist care). The primary objective was to describe SABA prescription patterns in the 12 months prior to the study visit. Results Overall, 579 patients were included (mean age [standard deviation; SD]: 47.4 [16.1] years; 74.3% female), all of whom were treated by specialists. Most patients had moderate-to-severe asthma (82.7%, GINA steps 3–5), were overweight or obese (70.5%), had high school or university/post-graduate education (51.8%) and reported fully reimbursed healthcare (97.1%). The mean (SD) asthma duration was 12.0 (9.9) years. Asthma was partly controlled/uncontrolled in 56.3% of patients, and 46.5% experienced ≥ 1 severe exacerbation in the preceding 12 months. Overall, 23.9% of patients were prescribed ≥ 3 SABA canisters in the previous 12 months (considered over-prescription); 42.9% received no SABA prescriptions. As few patients had mild asthma, only 5.7% were prescribed SABA monotherapy. Therefore, most patients (61.5%) were prescribed SABA in addition to maintenance therapy, with 42.8% receiving ≥ 3 SABA canisters in the previous 12 months. Inhaled corticosteroids (ICS), ICS + a long-acting β-agonist fixed-dose combination and oral corticosteroids were prescribed to 14.5%, 88.3% and 28.5% of all patients, respectively. Additionally, 10.2% of patients purchased SABA over the counter, of whom 27.1% purchased ≥ 3 canisters in the preceding 12 months. Conclusions Despite all patients being treated by specialists and most receiving fully reimbursed healthcare, nearly a quarter of patients received prescriptions for ≥ 3 SABA canisters in the previous 12 months. This highlights a public health concern and emphasizes the need to align clinical practices with the latest evidence-based recommendations. Supplementary Information The online version contains supplementary material available at 10.1186/s12890-022-02008-9.
Collapse
Affiliation(s)
- Arzu Yorgancıoğlu
- Department of Pulmonology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
| | - Kurtuluş Aksu
- Division of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey
| | - Sibel Atış Naycı
- Department of Pulmonology, Faculty of Medicine, Mersin University, Mersin, Turkey
| | - Dane Ediger
- Division of Allergy and Immunology, Department of Pulmonology, Faculty of Medicine, Bursa Uludağ University, Bursa, Turkey
| | - Dilşad Mungan
- Department of Pulmonology, Division of Allergy and Immunology, Faculty of Medicine, Ankara University, Ankara, Turkey
| | | | | | | |
Collapse
|
10
|
Lee L, Locklin J, Patel T, Lu SK, Hillier LM. Recruitment of participants for dementia research: interprofessional perspectives from primary care-based memory clinics. Neurodegener Dis Manag 2022; 12:117-127. [PMID: 35377732 DOI: 10.2217/nmt-2021-0053] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aim: To understand clinician attitudes and the barriers that impede research recruitment from specialized primary care-based memory clinics. Materials & methods: Clinicians completed a survey on attitudes and barriers to research recruitment from memory clinics. Results: Comfort and willingness to recruit for research were low to moderate and were lower for drug trials than for observational and non-drug trials. Respondents believed that it is important to have a standardized recruitment process. Identified barriers provide some insights into the factors that contribute to discomfort and lack of willingness to recruit research participants. Discussion: Findings can inform future efforts to develop a recruitment process that addresses identified barriers, while also providing an opportunity to increase participant recruitment in dementia research.
Collapse
Affiliation(s)
- Linda Lee
- Centre for Family Medicine Family Health Team, 10B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada.,Department of Family Medicine, McMaster University, 100 Main Street West, Hamilton, Ontario, L8P 1H6, Canada.,Schlegel-University of Waterloo Research Institute for Aging, 250 Laurelwood Drive, Waterloo, Ontario, N2J 0E2, Canada
| | - Jason Locklin
- Centre for Family Medicine Family Health Team, 10B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
| | - Tejal Patel
- Centre for Family Medicine Family Health Team, 10B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada.,School of Pharmacy, University of Waterloo, 10A Victoria Street South, Waterloo, Ontario, N2G 1C5, Canada
| | - Stephanie K Lu
- Centre for Family Medicine Family Health Team, 10B Victoria Street South, Kitchener, Ontario, N2G 1C5, Canada
| | - Loretta M Hillier
- GERAS Centre for Aging Research, 88 Maplewood Ave, Hamilton, Ontario, L8M 1W9, Canada
| |
Collapse
|
11
|
Mudaranthakam DP, Alsup AM, Murakonda V, Lin T, Thompson J, Gajewski B, Mayo MS. Accelerating Cancer Patient Recruitment Through a Mobile Application (Clinical Trial Finder). Cancer Inform 2022; 21:11769351211073114. [PMID: 35095270 PMCID: PMC8793431 DOI: 10.1177/11769351211073114] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Accepted: 12/22/2021] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVE Participant recruitment is a challenge for any clinical trial but is especially complex in cancer specifically due to the need to initiate treatment urgently. Most participants enrolled in oncology clinical trials are identified as potential participants by the oncologist or other referring provider. Optimal clinical care for patients with cancer includes consideration of participation in a clinical trial. However, the process of finding a clinical trial that is appropriate the patient can be cumbersome and time consuming. MATERIAL AND METHODS The University of Kansas Cancer Center has developed a mobile application (app) which streamlines the clinical trial search process for physicians, patients, and caregivers by cohesively integrating all clinical trials currently recruiting in the center and making them easy to browse. RESULTS Key aspects of the app include simple filtering options, the ability to search for trials by name, easily accessible assistance, and in-app referral by phone or email. Initial feedback on the app has been very positive, with several suggestions already being implemented in future development. The app was designed to be used both by physicians to find trials, as well as patients in collaboration with their physicians. CONCLUSION While long-term results will be crucial to understanding how the app can best serve our patient population, our initial results suggest that health system specific clinical trial apps can address a currently unmet need in the clinical trial recruitment process.
Collapse
Affiliation(s)
- Dinesh Pal Mudaranthakam
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
- The University of Kansas Cancer Center,
Kansas City, KS, USA
| | - Alexander M Alsup
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
| | - Vinay Murakonda
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
| | - Tara Lin
- The University of Kansas Cancer Center,
Kansas City, KS, USA
| | - Jeffrey Thompson
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
- The University of Kansas Cancer Center,
Kansas City, KS, USA
| | - Byron Gajewski
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
- The University of Kansas Cancer Center,
Kansas City, KS, USA
| | - Matthew S Mayo
- Department of Biostatistics & Data
Science, University of Kansas Medical Center, Kansas City, KS, USA
- The University of Kansas Cancer Center,
Kansas City, KS, USA
| |
Collapse
|
12
|
Abbott P, Askew D, Watego C, Hu WC, Campbell L, Tyson C, Walsh R, Hussey S, Doyle K, Gunasekera H, Leach AJ, Usherwood T, Armstrong-Kearns J, Reath J. Randomised clinical trial research within Aboriginal and Torres Strait Islander primary health services: a qualitative study. BMJ Open 2021; 11:e050839. [PMID: 34952874 PMCID: PMC8710871 DOI: 10.1136/bmjopen-2021-050839] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
OBJECTIVE To better understand how to undertake valuable, ethical and sustainable randomised controlled clinical trial (RCT) research within Aboriginal and Torres Strait Islander primary health services. DESIGN In a qualitative approach, we utilised data collected between 2013 and 2020 during the planning and implementation of two RCTs. The data comprised agreed records of research meetings, and semistructured interviews with clinical trial stakeholders. The stakeholders were parents/carers of child participants, and site-based research officers, healthcare providers and community advisory groups. Our thematic analysis was informed by constructivist grounded theory. SETTING The RCTs investigated the management of otitis media in Aboriginal and Torres Strait Islander children, with the first RCT commencing recruitment in 2014 and the second in 2017. They took place in Aboriginal Medical Services (AMSs), large primary health services for Aboriginal and Torres Strait Islander people, based in urban and regional communities across two Australian states and one territory. RESULTS We analysed data from 56 meetings and 67 interviews, generating themes on making research valuable and undertaking ethical and sustainable RCTs. Aboriginal and Torres Strait Islander leadership, and support of AMSs in their service delivery function were critical. The broad benefits of the trials were considered important to sustainability, including workforce development, enhanced ear healthcare and multidirectional research capacity building. Participants emphasised the long-term responsibility of research teams to deliver benefits to AMSs and communities regardless of RCT outcomes, and to focus on relationships, reciprocity and creating positive experiences of research. CONCLUSION We identify principles and strategies to assist in undertaking ethical and sustainable RCTs within Aboriginal and Torres Strait Islander primary health services. Maintaining relationships with AMSs and focusing on mutual workforce development and capacity building creates opportunities for long-term benefits so that health research and RCTs work for Aboriginal and Torres Strait Islander peoples, services, communities and researchers. TRIAL REGISTRATION NUMBER ACTRN12613001068752 (Pre-results); ACTRN12617001652369 (Pre-results).
Collapse
Affiliation(s)
- Penelope Abbott
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
| | - Deborah Askew
- Primary Care Clinical Unit, University of Queensland, Brisbane, Queensland, Australia
| | - Chelsea Watego
- School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Wendy Cy Hu
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
| | - Letitia Campbell
- Kalwun Development Corporation, Gold Coast, Queensland, Australia
| | - Claudette Tyson
- Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care, Brisbane, Queensland, Australia
| | - Robyn Walsh
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
| | - Sylvia Hussey
- Townsville Aboriginal and Islander Health Service, Townsville, Queensland, Australia
| | - Kerrie Doyle
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
| | | | - Amanda Jane Leach
- Child Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia
| | - Tim Usherwood
- University of Sydney, Sydney, New South Wales, Australia
| | | | - Jennifer Reath
- School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
| |
Collapse
|
13
|
Passmore SR, Kisicki A, Gilmore-Bykovskyi A, Green-Harris G, Edwards DF. "There's not much we can do…" researcher-level barriers to the inclusion of underrepresented participants in translational research. J Clin Transl Sci 2021; 6:e4. [PMID: 35154814 PMCID: PMC8807123 DOI: 10.1017/cts.2021.876] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 11/03/2021] [Accepted: 11/08/2021] [Indexed: 12/13/2022] Open
Abstract
INTRODUCTION The lack of diversity in health research participation has serious consequences for science as well as ethics. While there is growing interest in solving the problem, much of the work to date focuses on attitudes of distrust among members of underrepresented communities. However, there is also a pressing need to understand existing barriers within the cultural and structural context of researchers and research staff. METHODS This study adopted a sequential exploratory mixed-methods design to allow for a focused examination of barriers to inclusive research recruitment among researchers and staff. Barriers first identified from an initial quantitative investigation (web-based survey; n = 279) were further explored through qualitative methods (key informant interviews; n = 26). Participants were investigators and research team members in both phases of the study. RESULTS The survey revealed a paradoxical disconnect between participants' reported belief in the abstract value of diversity in research participation (87.1% important/extremely important) and belief in it as an important goal in their own specific research (38.3% important/extremely important). Interviews reveal that researchers and staff perceive many barriers to the recruitment of members of underrepresented groups and hold a general view of diversity in research as an impractical, even unattainable, goal. CONCLUSIONS It is crucial that principal investigators not only understand the consequences of the continued exclusion of marginalized groups from research but also implement strategies to reverse this trend and communicate with research staff on the issue. While individual bias does play a role (ex: a priori assumptions about the willingness or ability of members of underrepresented groups to participate), these behaviors are part of a larger context of systemic racism.
Collapse
Affiliation(s)
- Susan Racine Passmore
- Collaborative Center for Health Equity, Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, USA
| | - Abby Kisicki
- Collaborative Center for Health Equity, Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, USA
| | | | - Gina Green-Harris
- Center for Community Engagement and Health Partnerships, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
| | - Dorothy Farrar Edwards
- Collaborative Center for Health Equity, Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, USA
- Department of Kinesiology, School of Education, University of Wisconsin, Madison, WI, USA
- Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA
| |
Collapse
|
14
|
Options for Meaningful Engagement in Clinical Research for Busy Frontline Clinicians. J Gen Intern Med 2021; 36:2100-2104. [PMID: 33528778 PMCID: PMC8298624 DOI: 10.1007/s11606-020-06587-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Accepted: 12/30/2020] [Indexed: 10/22/2022]
Abstract
In order for health care innovations to be effective and actionable, they must align with the needs and practice patterns of those delivering care at the bedside. While research has started to incorporate the patient voice, it has yet to fully invest in the expertise of frontline clinicians. Frontline clinicians carry a wealth of clinical knowledge and the lived experience of providing real-world medical care that the research community seeks to improve. We consider options for clinicians as research stakeholders along a continuum of engagement as outlined by the UCSF Clinical and Translational Science Institute from minimal to supportive to participatory. In order to make an effective value proposition to support reallocation of clinician time to research engagement, we advocate evaluating the impact of clinicians as stakeholders at both the process level (e.g., clinician satisfaction, study recruitment rates) and endpoint level (e.g., clinical outcomes). Investing in clinicians as research stakeholders can offer benefits for the individual, health system, and population by increasing the generalizability, adoption, and sustainability of effective interventions.
Collapse
|